COVID-19 in the urban built environment (CUBE): SARS-CoV-2 prevalence in high traffic hospital settings

城市建筑环境 (CUBE) 中的 COVID-19：人流量大的医院环境中的 SARS-CoV-2 患病率

• 批准号: 554478-2020
• 负责人: Kassen, Rees
• 金额: $ 3.64万
• 依托单位: University of Ottawa
• 依托单位国家: 加拿大
• 项目类别: Alliance Grants
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=705645
• 关键词: COVID; 19; urban; built; environment

Understanding the distribution and prevalence of SARS-CoV-2, the virus that causes COVID-19, in and around COVID-19 treatment centers is a high priority for physicians, other front-line health care workers, hospital administrators, and public health agencies. Put simply, we need to know whether and where the virus is present in order to safeguard front line workers and reduce spread. Our project will provide this data. Working with industry partner DNA Genotek and hospital-based surveillance programs and infection prevention and control (IPAC) programs at The Ottawa Hospital, we will refine technologies for recoverhing viral genetic material from commonly-touched built surfaces in the hospital setting and track the prevalence of the virus over time in high traffic areas in and around hospital treatment sites. This work is directly aligned with a OneHealth perspective linking environmental and human health and represents a proof-of-principle initiative in surveillance biogeography of the urban microbiome that could be expanded to additional high traffic sites beyond the hospital such as schools, community centres, and shopping malls.

了解SARS-CoV-2（引起COVID-19的病毒）在COVID-19治疗中心及其周围的分布和流行情况是医生、其他一线医护人员、医院管理人员和公共卫生机构的首要任务。简而言之，我们需要知道病毒是否存在以及在哪里存在，以保护一线工作人员并减少传播。我们的项目将提供这些数据。与行业合作伙伴DNA Genotek和渥太华医院的医院监测计划和感染预防和控制（IPAC）计划合作，我们将改进从医院环境中经常接触的建筑表面回收病毒遗传物质的技术，并跟踪医院治疗场所内和周围高流量区域的病毒流行情况。这项工作直接符合OneHealth的观点，将环境和人类健康联系起来，代表了城市微生物组监测生态学的原则证明倡议，可以扩展到医院以外的其他高流量场所，如学校，社区中心和购物中心。